• Explore /
  • Poster
  • / Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases, first results from a phase III randomized controlled multicenter trial (the SCANDIUM trial).

Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases, first results from a phase III randomized controlled multicenter trial (the SCANDIUM trial).

Abstract Poster

Authors

Roger Olofsson Bagge

Roger Olofsson Bagge

Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden

Roger Olofsson Bagge , Axel Nelson , Amir Shafazand , Charlotta All-Ericsson , Christian Cahlin , Nils Elander , Hildur Helgadottir , Jens Folke Kiilgaard , Sara Kinhult , Ingrid Ljuslinder , Magnus Rizell , Malin Sternby Eilard , Gustav J. Ullenhag , Jonas A Nilsson , Lars Ny , Per Lindner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT01785316

Citation

J Clin Oncol 40, 2022 (suppl 17; abstr LBA9509)

DOI

10.1200/JCO.2022.40.17_suppl.LBA9509

Abstract #

LBA9509

Poster Bd #

103

Abstract Disclosures

Similar Posters

First Author: Roger Olofsson Bagge

First Author: Roger Olofsson Bagge

First Author: Rino S Seedor

First Author: Serge Leyvraz